Targeting DNA Damage Response as a Strategy to Treat HPV Infections
Autor: | N. Sanjib Banerjee, Dianne W. Moore, Louise T. Chow, Thomas R. Broker, Cameron J. Parker |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Keratinocytes Male cervical cancer Cellular differentiation Papillomavirus E7 Proteins Uterine Cervical Neoplasms Virus Replication lcsh:Chemistry 0302 clinical medicine lcsh:QH301-705.5 Spectroscopy Cells Cultured Cervical cancer Cell Death Human papillomavirus 18 MK-8776 HPV infection General Medicine 3. Good health Computer Science Applications 030220 oncology & carcinogenesis Chk1 inhibitor Female medicine.drug Programmed cell death Combination therapy DNA damage Antineoplastic Agents raft culture DDR Catalysis Article Inorganic Chemistry 03 medical and health sciences Cell Line Tumor medicine Humans Physical and Theoretical Chemistry Molecular Biology Protein Kinase Inhibitors Cisplatin business.industry Organic Chemistry Papillomavirus Infections medicine.disease HPV productive infection 030104 developmental biology Pyrimidines lcsh:Biology (General) lcsh:QD1-999 Apoptosis DNA Viral Cancer research Pyrazoles business HeLa Cells |
Zdroj: | International Journal of Molecular Sciences Volume 20 Issue 21 International Journal of Molecular Sciences, Vol 20, Iss 21, p 5455 (2019) |
ISSN: | 1422-0067 |
Popis: | Mucosotropic human papillomaviruses (HPVs) cause prevalent anogenital infections, some of which can progress to cancers. It is imperative to identify efficacious drug candidates, as there are few therapeutic options. We have recapitulated a robust productive program of HPV-18 in organotypic raft cultures of primary human keratinocytes. The HPV E7 protein induces S phase reentry, along with DNA damage response (DDR) in differentiated cells to support viral DNA amplification. A number of small molecule inhibitors of DDR regulators are in clinical use or clinical trials to treat cancers. Here, we used our raft culture system to examine effects of inhibitors of ATR/Chk1 and ATM/Chk2 on HPV infection. The inhibitors impaired S-phase reentry and progression as well as HPV DNA amplification. The Chk1 inhibitor MK-8776 was most effective, reducing viral DNA amplification by 90&ndash 99% and caused DNA damage and apoptosis, preferentially in HPV infected cells. We found that this sensitivity was imparted by the E7 protein and report that MK-8776 also caused extensive cell death of cervical cancer cell lines. Furthermore, it sensitized the cells to cisplatin, commonly used to treat advanced cervical cancer. Based on these observations, the Chk1 inhibitors could be potential effective agents to be re-purposed to treat the spectrum of HPV infections in single or combination therapy. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |